作为抗癌药物的无机环状系统新设计。X = F、Az、Ph时氮丙啶基（乙撑亚胺基）衍生物（NPAz2）2NSOX的抗肿瘤活性。 - Suppr | 超能文献

New designs in inorganic ring systems as anticancer drugs. Antitumor activity of the aziridino (ethylene-imino) derivatives (NPAz2)2NSOX with X = F, Az, Ph.

作者信息

Labarre J F, Sournies F, Cros S, François G, van de Grampel J C, van der Huizen A A

出版信息

Cancer Lett. 1981 Apr;12(3):245-50. doi: 10.1016/0304-3835(81)90075-6.

DOI:10.1016/0304-3835(81)90075-6

Abstract

摘要

文献AI研究员

20分钟写一篇综述，助力文献阅读效率提升50倍。

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

文档翻译

学术文献翻译模型，支持多种主流文档格式。

相似文献

1

New designs in inorganic ring systems as anticancer drugs. Antitumor activity of the aziridino (ethylene-imino) derivatives (NPAz2)2NSOX with X = F, Az, Ph.作为抗癌药物的无机环状系统新设计。X = F、Az、Ph时氮丙啶基（乙撑亚胺基）衍生物（NPAz2）2NSOX的抗肿瘤活性。

Cancer Lett. 1981 Apr;12(3):245-50. doi: 10.1016/0304-3835(81)90075-6.

2

Antitumour activity of some cyclophosphazenes.某些环磷腈的抗肿瘤活性。

Eur J Cancer (1965). 1979 May;15(5):637-43. doi: 10.1016/0014-2964(79)90137-3.

3

Experimental antitumor activity and toxicity of a new chemotherapeutic agent, BBM 928A.新型化疗药物BBM 928A的实验性抗肿瘤活性与毒性

Cancer Res. 1983 Apr;43(4):1504-10.

4

Up-to-date improvements in inorganic ring systems as anticancer agents.无机环状系统作为抗癌剂的最新进展。

Top Curr Chem. 1982;102:1-87. doi: 10.1007/3-540-11345-2_7.

5

Antitumor activity of pyrazofurin in combination with 5-azacytidine against murine P388 and L1210 leukemias and colon carcinoma 26.吡唑呋喃与5-氮杂胞苷联合对小鼠P388和L1210白血病及结肠癌26的抗肿瘤活性。

Cancer Treat Rep. 1979 Nov-Dec;63(11-12):1857-62.

6

[Psychotropic drugs and new 1,5-benzodiazepine analogs as antitumor agents].

Folia Haematol Int Mag Klin Morphol Blutforsch. 1981;108(5):637-42.

7

In vivo antitumor activity of 6-benzyl-1,3-benzodioxole derivatives against the P388, L1210, B16, and M5076 murine models.6-苄基-1,3-苯并二恶唑衍生物对P388、L1210、B16和M5076小鼠模型的体内抗肿瘤活性。

J Med Chem. 1987 Oct;30(10):1752-6. doi: 10.1021/jm00393a012.

8

Synthesis and antitumor activity of 4-[p-[bis(2-chloroethyl)amino]phenyl]butyrates.4-[对-[双(2-氯乙基)氨基]苯基]丁酸酯的合成及其抗肿瘤活性

J Pharm Sci. 1980 Oct;69(10):1232-4.

9

In vivo and in vitro anticancer activity of the structurally novel and highly potent antibiotic CI-940 and its hydroxy analog (PD 114,721).结构新颖且高效的抗生素CI-940及其羟基类似物（PD 114,721）的体内和体外抗癌活性

Cancer Chemother Pharmacol. 1986;16(2):95-101. doi: 10.1007/BF00256156.

10

Effect of 3'-amino-3'-deoxythymidine on L1210 and P388 leukemias in mice.3'-氨基-3'-脱氧胸苷对小鼠L1210和P388白血病的作用。

Biochem Pharmacol. 1982 Jan 1;31(1):125-8. doi: 10.1016/0006-2952(82)90250-7.

引用本文的文献

1

Phase I clinical trial of (NPAz2)2NSOAz: 'SOAz'.（NPAz2）2NSOAz（“SOAz”）的I期临床试验

Cancer Chemother Pharmacol. 1983;10(3):178-81. doi: 10.1007/BF00255757.

2

Clinical pharmacokinetics of (NPAz2)2NSOAz: 'SOAz'.（NPAz2）2NSOAz（即'SOAz'）的临床药代动力学

Cancer Chemother Pharmacol. 1983;10(3):174-7. doi: 10.1007/BF00255756.

3

Determination of the antitumor agent SOAz (1,3,3,5,5 pentakis(aziridino)-1 lambda 6,2,4,6,3 lambda 5, 5 lambda 5 thia-triazadiphosphorine-1-oxide) by a gas chromatographic assay suitable for pharmacokinetic studies in man.采用适用于人体药代动力学研究的气相色谱分析法测定抗肿瘤药物SOAz（1,3,3,5,5-五（氮丙啶基）-1λ⁶,2,4,6,3λ⁵,5λ⁵-硫杂三氮二磷-1-氧化物）。

Cancer Chemother Pharmacol. 1983;10(3):170-3. doi: 10.1007/BF00255755.